Company Profile
Public information reviewedADC Therapeutics SA
ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors.
USNYSE: ADCT
Follow
More
- Evidence records
- 2
- Published leadership records
- 12
- Record reviewed
- Sep 26, 2026

